Publications by authors named "Julia Bottomley"

Claim this Profile
A
A psoriasis-specific model to support decision making in practice - UK experience.
Keith Freeman, Maggie Marum, Julia M Bottomley, Merran Auland, Peter Jackson

Curr Med Res Opin· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland.
Andrew G Affleck, Julia M Bottomley, Merran Auland, Peter Jackson, Jacob Ryttov

Curr Med Res Opin· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity in the treatment of moderately severe scalp psoriasis in Scotland - results of a survey of Scottish health professionals.
Douglas R W Smith, Julia M Bottomley, Merran Auland, Peter Jackson, Judith Sharp

Curr Med Res Opin· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness of two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of moderately severe scalp psoriasis: a systematic review of direct and indirect evidence.
Julia M Bottomley, Rod S Taylor, Jacob Ryttov

Curr Med Res Opin· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmaco-economic issues for diabetes therapy.
Julia M Bottomley, Frank D Raymond

Best Pract Res Clin Endocrinol Metab· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
Julia M Bottomley, Merran E Auland, Jeremy Morais, Gordon Boyd, W Stewart Douglas

Curr Med Res Opin· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A lifetime modelled economic evaluation comparing pioglitazone and rosiglitazone for the treatment of type 2 diabetes mellitus in the UK.
Dominic P Tilden, Segundo Mariz, Gillies O'Bryan-Tear, Julia Bottomley, Alexander Diamantopoulos

Pharmacoeconomics· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do people with type 2 diabetes and their carers lose income? (T2ARDIS-4).
Jeremy Holmes, Elena Gear, Julia Bottomley, Stephen Gillam, Moira Murphy

Health Policy· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis